Casdin Partners Master Fund, L.P. sold BLFS
October 15, 2025 · Form 4 insider transaction
Casdin Partners Master Fund, L.P. sold 750,000 shares of BioLife Solutions, Inc. at $28.55 per share, a transaction worth $21.41M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $28.50 to $28.8354. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.; The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC ("Casdin Capital"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.